Curcumin-altered p53-response genes regulate radiosensitivity in p53-mutant Ewing's sarcoma cells

Anticancer Research

Volumn 30, Issue 10, 2010, Pages 4007-4015

  Veeraraghavan, J ^a   Natarajan, M ^b   Herman, T S ^a   Aravindan, Natarajan ^a  

^a UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

Apoptosis; Curcumin; Ewing's sarcoma; p53; Radiosensitivity

Indexed keywords

CURCUMIN; DNA; PROTEIN BAX; PROTEIN BCL 2; PROTEIN BCL XL; PROTEIN MCL 1; PROTEIN P21; PROTEIN P53;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CELL CYCLE ARREST; CELL EXPANSION; CELL SURVIVAL; CONTROLLED STUDY; DNA DAMAGE; DNA FRAGMENTATION; DRUG CYTOTOXICITY; EWING SARCOMA; GENE CONTROL; GENE EXPRESSION; HUMAN; HUMAN CELL; MUTANT; PRIORITY JOURNAL; RADIATION EXPOSURE; RADIOSENSITIZATION; SARCOMA CELL; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION; TRANSLATION INITIATION;

APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; COMBINED MODALITY THERAPY; CURCUMIN; GENES, P53; HUMANS; INFRARED RAYS; MUTATION; PROTO-ONCOGENE PROTEINS C-BCL-2; RADIATION TOLERANCE; RADIATION-SENSITIZING AGENTS; SARCOMA, EWING'S; SIGNAL TRANSDUCTION; TRANSCRIPTION, GENETIC;

EID: 78650237844     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. Maheshwari AV and Cheng EY: Ewing sarcoma family of tumors. J Am Acad Orthop Surg 18: 94-107, 2010.
2. McGinn CJ and Kinsella TJ: The experimental and clinical rationale for the use of S-phase-specific radiosensitizers to overcome tumor cell repopulation. Semin Oncol 19: 21-28, 1992.
3. Dunst J and Schuck A: Role of radiotherapy in Ewing tumors. Pediatr Blood Cancer 42: 465-470, 2004.
4. Bolek TW, Marcus RB, Jr., Mendenhall NP, Scarborough MT and Graham-Pole J: Local control and functional results after twice-daily radiotherapy for Ewing's sarcoma of the extremities. Int J Radiat Oncol Biol Phys 35: 687-692, 1996.
5. Paulino AC: Late effects of radiotherapy for pediatric extremity sarcomas. Int J Radiat Oncol Biol Phys 60: 265-274, 2004.
6. Kovar H, Pospisilova S, Jug G, Printz D and Gadner H: Response of Ewing tumor cells to forced and activated p53 expression. Oncogene 22: 3193-3204, 2003.
7. Aggarwal BB and Shishodia S: Molecular targets of dietary agents for prevention and therapy of cancer. Biochem Pharmacol 71: 1397-1421, 2006.
8. Chainani-Wu N: Safety and anti-inflammatory activity of curcumin: a component of tumeric (Curcuma longa). J Altern Complement Med 9: 161-168, 2003.
9. Kelloff GJ, Crowell JA, Hawk ET, Steele VE, Lubet RA, Boone CW, Covey JM, Doody LA, Omenn GS, Greenwald P, Hong WK, Parkinson DR, Bagheri D, Baxter GT, Blunden M, Doeltz MK, Eisenhauer KM, Johnson K, Knapp GG, Longfellow DG, Malone WF, Nayfield SG, Seifried HE, Swall LM and Sigman CC: Strategy and planning for chemopreventive drug development: clinical development plans II. J Cell Biochem Suppl 26: 54-71, 1996.
10. Cheng AL, Hsu CH, Lin JK, Hsu MM, Ho YF, Shen TS, Ko JY, Lin JT, Lin BR, Ming-Shiang W, Yu HS, Jee SH, Chen GS, Chen TM, Chen CA, Lai MK, Pu YS, Pan MH, Wang YJ, Tsai CC and Hsieh CY: Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions. Anticancer Res 21: 2895-2900, 2001.
11. Yang F, Lim GP, Begum AN, Ubeda OJ, Simmons MR, Ambegaokar SS, Chen PP, Kayed R, Glabe CG, Frautschy SA and Cole GM: Curcumin inhibits formation of amyloid beta oligomers and fibrils, binds plaques, and reduces amyloid in vivo. J Biol Chem 280: 5892-5901, 2005
12. Lim JH and Kwon TK: Curcumin inhibits phorbol myristate acetate (PMA)-induced MCP-1 expression by inhibiting ERK and NF-kappaB transcriptional activity. Food Chem Toxicol 48: 47-52, 2010.
13. Hartojo W, Silvers AL, Thomas DG, Seder CW, Lin L, Rao H, Wang Z, Greenson JK, Giordano TJ, Orringer MB, Rehemtulla A, Bhojani MS, Beer DG and Chang AC: Curcumin promotes apoptosis, increases chemosensitivity, and inhibits nuclear factor kappaB in esophageal adenocarcinoma. Transi Oncol 3: 99-108, 2010.
14. Schaaf C, Shan B, Onofri C, Stalla GK, Arzt E, Schilling T, Perone MJ and Renner U: Curcumin inhibits the growth, induces apoptosis and modulates the function of pituitary folliculostellate cells. Neuroendocrinology 91: 200-210, 2010.
15. Huang MT, Lou YR, Xie JG, Ma W, Lu YP, Yen P, Zhu BT, Newmark H and Ho CT: Effect of dietary curcumin and dibenzoylmethane on formation of 7,12-dimethylbenz[a] anthracene-induced mammary tumors and lymphomas/leukemias in Senear mice. Carcinogenesis 19: 1697-1700, 1998.
16. Lee JC, Kinniry PA, Arguiri E, Serota M, Kanterakis S, Chatterjee S, Solomides CC, Javvadi P, Koumenis C, Cengel KA and Christofidou-Solomidou M: Dietary curcumin increases antioxidant defenses in lung, ameliorates radiation-induced pulmonary fibrosis, and improves survival in mice. Radiat Res 173: 590-601, 2010.
17. Watson JL, Greenshields A, Hill R, Hilchie A, Lee PW, Giacomantonio CA and Hoskin DW: Curcumin-induced apoptosis in ovarian carcinoma cells is p53-independent and involves p38 mitogen-activated protein kinase activation and downregulation of Bcl-2 and survivin expression and Akt signaling. Mol Carcinog 49: 13-24, 2010.
18. 2/M arrest and apoptosis in cisplatin-resistant human ovarian cancer cells by modulating Akt and p38 MAPK. Cancer Biol Ther 6: 178-184, 2007
19. Shankar S and Srivastava RK: Involvement of Bcl-2 family members, phosphatidylinositol 3′-kinase/AKT and mitochondrial p53 in curcumin (diferulolylmethane)-induced apoptosis in prostate cancer. Int J Oncol 30: 905-918, 2007.
20. 2/M cell cycle arrest in a p53-dependent manner and upregulates ING4 expression in human glioma. J Neurooncol, 2007.
21. 2 phase of cell cycle in a p53-dependent manner. J Biol Chem 280: 20059-20068, 2005.
22. Liontas A and Yeger H: Curcumin and resveratrol induce apoptosis and nuclear translocation and activation of p53 in human neuroblastoma. Anticancer Res 24: 987-998, 2004.
23. Aravindan N, Madhusoodhanan R, Ahmad S, Johnson D and Herman TS: Curcumin inhibits NFkappaB-mediated radioprotection and modulate apoptosis related genes in human neuroblastoma cells. Cancer Biol Ther 7: 569-576, 2008
24. Aravindan N, Madhusoodhanan R, Natarajan M and Herman TS: Alteration of apoptotic signaling molecules as a function of time after radiation in human neuroblastoma cells. Mol Cell Biochem 310: 167-179, 2008.
25. Aravindan N, Shanmugasundaram K and Natarajan M: Hyperthermia-induced NFkappaB-mediated apoptosis in normal human monocytes. Mol Cell Biochem, 2009.
26. Madhusoodhanan R, Natarajan M, Veeraraghavan J, Herman TS and Aravindan N: NFkappaB activity and transcriptional responses in human breast adenocarcinoma cells after single and fractionated irradiation. Cancer Biol Ther 8, 2009.
27. Madhusoodhanan R, Natarajan M, Veeraraghavan J, Herman TS, Nisha S, Jamgade A and Aravindan N: NFkappaB Signaling Related Molecular Alterations in Human Neuroblastoma Cells after Fractionated Irradiation. J Radiat Res (Tokyo), 2009.
28. Davidoff AM, Pence JC, Shorter NA, Iglehart JD and Marks JR: Expression of p53 in human neuroblastoma- and neuroepithelioma-derived cell lines. Oncogene 7: 127-133, 1992.
29. Liang SX and Richardson DR: The effect of potent iron chelators on the regulation of p53: examination of the expression, localization and DNA-binding activity of p53 and the transactivation of WAFl. Carcinogenesis 24: 1601-1614, 2003.
30. Unger T, Mietz JA, Scheffner M, Yee CL and Howley PM: Functional domains of wild-type and mutant p53 proteins involved in transcriptional regulation, transdominant inhibition, and transformation suppression. Mol Cell Biol 13: 5186-5194, 1993.
31. Keshelava N, Zuo JJ, Chen P, et al.: Loss of p53 function confers high-level multidrug resistance in neuroblastoma cell lines. Cancer Res 61: 6185-6193, 2001.
32. 1 cyclin-dependent kinases. Cell 75: 805-816, 1993.
33. WAF-1/ciP1, apoptosis and differentiation by L-745,337, a selective PGH synthase-2 inhibitor, and salicylate in HT-29 cells. Apoptosis 4: 151-162, 1999.
34. Brugarolas J, Chandrasekaran C, Gordon JI, Beach D, Jacks T and Hannon GJ: Radiation-induced cell cycle arrest compromised by p21 deficiency. Nature 377: 552-557, 1995
35. Macleod KF, Sherry N, Hannon G, Beach D, Tokino T, Kinzler K, Vogelstein B and Jacks T: P53-dependent and independent expression of p21 during cell growth, differentiation, and DNA damage. Genes Dev 9: 935-944, 1995.
36. Shishodia S, Singh T and Chaturvedi MM: Modulation of transcription factors by curcumin. Adv Exp Med Biol 595: 127-148, 2007.
37. Chendil D, Ranga RS, Meigooni D, Sathishkumar S and Ahmed MM: Curcumin confers radiosensitizing effect in prostate cancer cell line PC-3. Oncogene 23: 1599-1607, 2004.
38. Jaiswal AS, Marlow BP, Gupta N and Narayan S: Beta-catenin-mediated transactivation and cell-cell adhesion pathways are important in curcumin (diferuylmethane)-induced growth arrest and apoptosis in colon cancer cells. Oncogene 21: 8414-8427, 2002.
39. Li M, Zhang Z, Hill DL, Wang H and Zhang R: Curcumin, a dietary component, has anticancer, chemosensitization, and radiosensitization effects by down-regulating the MDM2 oncogene through the PI3K/mTOR/ETS2 pathway. Cancer Res 67: 1988-1996, 2007.
40. Dorai T, Cao YC, Dorai B, Buttyan R and Katz AE: Therapeutic potential of curcumin in human prostate cancer. III. Curcumin inhibits proliferation, induces apoptosis, and inhibits angiogenesis of LNCaP prostate cancer cells in vivo. Prostate 47: 293-303, 2001.
41. Mukhopadhyay A, Bueso-Ramos C, Chatterjee D, Pantazis P and Aggarwal BB: Curcumin down-regulates cell survival mechanisms in human prostate cancer cell lines. Oncogene 20: 7597-7609, 2001.
42. Jiang MC, Yang-Yen HF, Yen JJ and Lin JK: Curcumin induces apoptosis in immortalized NIH 3T3 and malignant cancer cell lines. Nutr Cancer 26: 111-120, 1996.
43. Choudhuri T, Pal S, Agwarwal ML, Das T and Sa G: Curcumin induces apoptosis in human breast cancer cells through p53-dependent Box induction. FEBS Lett 512: 334-340, 2002.
44. Ramachandran C, Rodriguez S, Ramachandran R, Raveendran Nair PK, Fonseca H, Khatib Z, Escalon E and Melnick SJ: Expression profiles of apoptotic genes induced by curcumin in human breast cancer and mammary epithelial cell lines. Anticancer Res 25: 3293-3302, 2005.